Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats

Introduction and Objectives: Chronic liver inflammation may lead to hepatic cirrhosis, limiting its regenerative capacity. The clinical standard of care is transplantation, although stem cell therapy may be an alternative option. The study aim was to induce endogenous hematopoietic stem cells (HSCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luna Saldivar, Marcela M., Marino Martínez, Iván Alberto, Franco Molina, Moisés Armides, Rivera Morales, Lydia Guadalupe, Alarcón Galván, Gabriela, Cordero Pérez, Paula, Rojas Martínez, Augusto, Rodríguez Padilla, Cristina, Muñoz Espinosa, Linda Elsa
Formato: Artículo
Lenguaje:Spanish / Castilian
Publicado: 2019
Materias:
Acceso en línea:http://eprints.uanl.mx/22399/7/22399.pdf
_version_ 1824416511188533248
author De Luna Saldivar, Marcela M.
Marino Martínez, Iván Alberto
Franco Molina, Moisés Armides
Rivera Morales, Lydia Guadalupe
Alarcón Galván, Gabriela
Cordero Pérez, Paula
Rojas Martínez, Augusto
Rodríguez Padilla, Cristina
Muñoz Espinosa, Linda Elsa
author_facet De Luna Saldivar, Marcela M.
Marino Martínez, Iván Alberto
Franco Molina, Moisés Armides
Rivera Morales, Lydia Guadalupe
Alarcón Galván, Gabriela
Cordero Pérez, Paula
Rojas Martínez, Augusto
Rodríguez Padilla, Cristina
Muñoz Espinosa, Linda Elsa
author_sort De Luna Saldivar, Marcela M.
collection Repositorio Institucional
description Introduction and Objectives: Chronic liver inflammation may lead to hepatic cirrhosis, limiting its regenerative capacity. The clinical standard of care is transplantation, although stem cell therapy may be an alternative option. The study aim was to induce endogenous hematopoietic stem cells (HSCs) with granulocyte colony stimulating factor (G-CSF) and/or intravenous administration of adipose tissue-derived mesenchymal stem cells (MSCs) to decrease hepatic fibrosis in an experimental model. Material and methods: A liver fibrosis model was developed with femaleWistar rats via multiple intraperitoneal doses of carbon tetrachloride. Three rats were selected to confirm cirrhosis, and the rest were set into experimental groups to evaluate single and combined therapies of G-CSF-stimulated HSC mobilization and intravenous MSC administration. Results: Treatment with MSCs and G-CSF significantly improved alanine amino transferase levels, while treatment with G-CSF, MSCs, and G-CSF + MSCs decreased aspartate amino transferase levels. Hepatocyte growth factor (HGF) and interleukin 10 levels increased with MSC treatment. Transforming growth factor levels were lower with MSC treatment. Interleukin 1 and tumor necrosis factor alpha levels decreased in all treated groups. Histopathology showed that MSCs and G-CSF reduced liver fibrosis from F4 to F2. Conclusions: MSC treatment improves liver function, decreases hepatic fibrosis, and plays an antiinflammatory role;it promotes HGF levels and increased proliferating cell nuclear antigen when followed by MSC treatment mobilization using G-CSF. When these therapies were combined, however, fibrosis improvement was less evident.
format Article
id eprints-22399
institution UANL
language Spanish / Castilian
publishDate 2019
record_format eprints
spelling eprints-223992022-09-02T16:50:15Z http://eprints.uanl.mx/22399/ Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats De Luna Saldivar, Marcela M. Marino Martínez, Iván Alberto Franco Molina, Moisés Armides Rivera Morales, Lydia Guadalupe Alarcón Galván, Gabriela Cordero Pérez, Paula Rojas Martínez, Augusto Rodríguez Padilla, Cristina Muñoz Espinosa, Linda Elsa QH Historia Natural, Biología Introduction and Objectives: Chronic liver inflammation may lead to hepatic cirrhosis, limiting its regenerative capacity. The clinical standard of care is transplantation, although stem cell therapy may be an alternative option. The study aim was to induce endogenous hematopoietic stem cells (HSCs) with granulocyte colony stimulating factor (G-CSF) and/or intravenous administration of adipose tissue-derived mesenchymal stem cells (MSCs) to decrease hepatic fibrosis in an experimental model. Material and methods: A liver fibrosis model was developed with femaleWistar rats via multiple intraperitoneal doses of carbon tetrachloride. Three rats were selected to confirm cirrhosis, and the rest were set into experimental groups to evaluate single and combined therapies of G-CSF-stimulated HSC mobilization and intravenous MSC administration. Results: Treatment with MSCs and G-CSF significantly improved alanine amino transferase levels, while treatment with G-CSF, MSCs, and G-CSF + MSCs decreased aspartate amino transferase levels. Hepatocyte growth factor (HGF) and interleukin 10 levels increased with MSC treatment. Transforming growth factor levels were lower with MSC treatment. Interleukin 1 and tumor necrosis factor alpha levels decreased in all treated groups. Histopathology showed that MSCs and G-CSF reduced liver fibrosis from F4 to F2. Conclusions: MSC treatment improves liver function, decreases hepatic fibrosis, and plays an antiinflammatory role;it promotes HGF levels and increased proliferating cell nuclear antigen when followed by MSC treatment mobilization using G-CSF. When these therapies were combined, however, fibrosis improvement was less evident. 2019 Article PeerReviewed text es cc_by_nc_nd http://eprints.uanl.mx/22399/7/22399.pdf http://eprints.uanl.mx/22399/7.haspreviewThumbnailVersion/22399.pdf De Luna Saldivar, Marcela M. y Marino Martínez, Iván Alberto y Franco Molina, Moisés Armides y Rivera Morales, Lydia Guadalupe y Alarcón Galván, Gabriela y Cordero Pérez, Paula y Rojas Martínez, Augusto y Rodríguez Padilla, Cristina y Muñoz Espinosa, Linda Elsa (2019) Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats. Annals of hepatology, 18 (4). pp. 620-626. ISSN 1665-2681 http://doi.org/10.1016/j.aohep.2018.12.005 doi:10.1016/j.aohep.2018.12.005
spellingShingle QH Historia Natural, Biología
De Luna Saldivar, Marcela M.
Marino Martínez, Iván Alberto
Franco Molina, Moisés Armides
Rivera Morales, Lydia Guadalupe
Alarcón Galván, Gabriela
Cordero Pérez, Paula
Rojas Martínez, Augusto
Rodríguez Padilla, Cristina
Muñoz Espinosa, Linda Elsa
Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
title_full Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
title_fullStr Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
title_full_unstemmed Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
title_short Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats
title_sort advantages of adipose tissue stem cells over cd34 mobilization to decrease hepatic fibrosis in wistar rats
topic QH Historia Natural, Biología
url http://eprints.uanl.mx/22399/7/22399.pdf
work_keys_str_mv AT delunasaldivarmarcelam advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT marinomartinezivanalberto advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT francomolinamoisesarmides advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT riveramoraleslydiaguadalupe advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT alarcongalvangabriela advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT corderoperezpaula advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT rojasmartinezaugusto advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT rodriguezpadillacristina advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats
AT munozespinosalindaelsa advantagesofadiposetissuestemcellsovercd34mobilizationtodecreasehepaticfibrosisinwistarrats